Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
April 8, 2026
Host Jonathan Miller interviews CEO: Steven Lydeamore. He talks about the exponential growth on sales in the past year.